FDA Warning Letter — Glenmark Pharmaceuticals Limited

Case 708270 — FEI 3008565058

The FDA took a Warning Letter action against Glenmark Pharmaceuticals Limited on Jul 11, 2025 (Dhar, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Glenmark Pharmaceuticals Limited
Date
Jul 11, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Dhar (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.